Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-101 - Survival Benefit of Sequential Therapy in ALK Positive Olioprogressive NSCLC Patients After Crizotinib Resistance
16:45 - 18:00 | Presenter: Haiyan Xu | Author(s): Di Ma, Guangjian Yang, Junling Li, Xuezhi Hao, Puyuan Xing, Lu Yang, Yan Wang
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.01-109 - Treatment Duration—A More Reasonable Definition to Evaluate the Efficacy of Crizotinib in ALK Positive Advanced NSCLC
16:45 - 18:00 | Presenter: Guangjian Yang | Author(s): Di Ma, Junling Li, Puyuan Xing, Xuezhi Hao, Haiyan Xu, Yan Wang
- Abstract
Loading...
-
+
P2.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.13-04 - Outcomes of ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Crizotinib: A Multicenter Cohort Retrospective Study.
16:45 - 18:00 | Presenter: Di Ma | Author(s): Puyuan Xing, Qiang Wang, Xuezhi Hao, Mengzhao Wang, Yan Wang, Li Shan, Tao Xin, Li Liang, Hongge Liang, Yang Du, Zhaohui Zhang, Junling Li
- Abstract
Loading... -
+
P2.13-05 - Real-World Clinical Benefit of Continuing Crizotinib Beyond Progression Disease (CBPD) in Patients with Advanced ALK-Positive NSCLC.
16:45 - 18:00 | Presenter: Di Ma | Author(s): Puyuan Xing, Qiang Wang, Xuezhi Hao, Mengzhao Wang, Yan Wang, Li Shan, Tao Xin, Li Liang, Hongge Liang, Yang Du, Zhaohui Zhang, Junling Li
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.01-103 - Efficacy of Crizotinib in Chinese Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Multicenter Retrospective Study
12:00 - 13:30 | Presenter: Shouzheng Wang | Author(s): Puyuan Xing, Di Ma, Qiang Wang, Xuezhi Hao, Mengzhao Wang, Yan Wang, Li Shan, Tao Xin, Li Liang, Hongge Liang, Yang Du, Zhaohui Zhang, Junling Li
- Abstract
Loading... -
+
P3.01-47 - Clinical Characteristics and Outcome for Patients with Advanced Lung Adenocarcinoma Treated with First-Line Pemetrexed Plus Platinum
12:00 - 13:30 | Presenter: Xue Ji | Author(s): Xingsheng Hu, Yixiang Zhu, Yutao Liu, Lin Lin, Puyuan Xing, Xuezhi Hao, Yan Wang, Junling Li
- Abstract
Loading...
-
+
P3.13 - Targeted Therapy (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.13-17 - A Retrospective Study: Central Nervous System Response to Osimertinib in Patients with Advanced NSCLC
12:00 - 13:30 | Presenter: Yuxin Mu | Author(s): Puyuan Xing, Xuezhi Hao, Yan Wang, Junling Li
- Abstract
Loading...